Clinical Characteristics and Drug Susceptibility Profiling of Multidrug‐Resistant Pseudomonas aeruginosa Infections
International Journal of Clinical Practice · 2025-01 · 2025 (1)
DOI: 10.1155/ijcp/2755014 ↗Abstract
Objective: To investigate the epidemiology of Pseudomonas aeruginosa (PA) in hospitalized patients with PA respiratory infections and to analyze the clinical characteristics and antibiotic resistance profiles of drug‐resistant PA, providing valuable insights to inform clinical management strategies. Methods: A retrospective analysis of clinical data from hospitalized patients with PA respiratory infections was collected and analyzed to investigate the clinical features and their correlation with PA drug resistance. Results: In the study cohort, 34.1% ( n = 93) of patients were classified as having multidrug‐resistant Pseudomonas aeruginosa (MDR‐PA), while 65.9% ( n = 180) were non‐MDR‐PA. Logistic regression identified that male gender, ICU admission, hemiplegia, and mechanical ventilation were independent risk factors for MDR‐PA infection (all p < 0.05). Multivariate analysis showed male gender (OR 2.44, 95% CI 1.15–5.17) and hemiplegia (OR 2.99, 95% CI 1.02–8.82) as significant factors for MDR‐PA infection. Both analyses also confirmed mechanical ventilation as an independent risk factor for difficult‐to‐treat Pseudomonas aeruginosa (DTR‐PA) infections. MDR‐PA exhibited low susceptibility to meropenem (32.3%) and imipenem (18.3%), whereas aminoglycosides showed higher effectiveness, with over 80% susceptibility against MDR‐PA and more than 50% susceptibility against DTR‐PA. Conclusion: Male patients with hemiplegia should be closely monitored for MDR‐PA infections when PA is detected. Mechanical ventilation necessitates vigilance against DTR‐PA. Aminoglycoside‐based combination therapy offers an effective empirical option for resistant PA infections. These findings indicate the need for antimicrobial stewardship or infection control measures to address MDR‐PA and DTR‐PA infections.
EUVIMED